GlassScriptPhysician profile
Darian Yera
NPI 1528535507
$3,765.66
in general payments reported to CMS, 2019-2025
29 companies · $733 in 2025
The $733 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $801 · 2022: $817 · 2023: $879 · 2024: $535 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.03 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $594.73 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $352.29 | 2021-2025 | Myrbetriq, Xtandi |
| Myriad Genetic Laboratories, INC. | $304.46 | 2021-2024 | Prolaris |
| Blue Earth Diagnostics | $296.67 | 2022-2025 | Posluma |
| Sumitomo Pharma America, INC. | $248.29 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $185.09 | 2021-2023 | Aveed, Xiaflex, Edex |
| Tolmar Pharmaceuticals, INC. | $164.90 | 2021-2022 | |
| Boston Scientific Corporation | $164.16 | 2021-2025 | Axonics, Spaceoar System, Spaceoar Vue System - 10ml |
| Tolmar, INC. | $160.95 | 2023-2025 | Eligard |
| Coloplast Corp | $158.10 | 2022-2023 | Speedicath, Self-Cath |
| Procept Biorobotics Corporation | $147.42 | 2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $144.19 | 2025 | Adstiladrin |
| Pfizer INC. | $136.43 | 2021-2024 | |
| Abbvie INC. | $103.38 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $82.23 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $74.10 | 2021-2025 | Barrigel |
| Axonics, INC. | $52.29 | 2022-2023 | Axonics |
| Dendreon Pharmaceuticals LLC | $50.03 | 2021-2022 | |
| Urovant Sciences INC | $48.10 | 2022 | |
| Antares Pharma, INC. | $47.91 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Endo USA, INC. | $42.68 | 2024-2025 | Aveed, Xiaflex |
| Convatec INC. | $39.43 | 2023 | |
| Allergan, INC. | $38.16 | 2021 | |
| Halozyme INC | $29.71 | 2023 | |
| Urogen Pharma, INC. | $26.80 | 2025 | |
| Mission Pharmacal Company | $24.23 | 2021-2022 | |
| Bioprotect Medical, INC. | $21.41 | 2025 | Bioprotect Balloon Implant System |
| Dentsply Ih Ab | $14.11 | 2023 | Lofric |
| Verity Pharmaceuticals INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darian Yera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.